Evidence map›Paper›PMID 23589855›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Critical role for miR-181a/b-1 in agonist selection of invariant natural killer T cells.

Natalia Ziętara, Marcin Łyszkiewicz, Katrin Witzlau, Ronald Naumann, Robert Hurwitz, Jörg Langemeier, Jens Bohne, Inga Sandrock, Matthias Ballmaier, Siegfried Weiss and 2 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed.

  1. Review
  2. Review
  3. Expert opinion on therapeutic targets · 2024
    Review
  4. Article
  5. Review
  6. The IL-17 family in diseases: from bench to bedside.Signal transduction and targeted therapy · 2023
    Review
  7. MicroRNAs in T Cell-Immunotherapy.International journal of molecular sciences · 2022
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. microRNA dynamic expression regulates invariant NKT cells.Cellular and molecular life sciences : CMLS · 2021
    Review
  15. Review
  16. Mitochondrial metabolism is essential for invariant natural killer T cell development and function.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  17. Article
  18. Article
  19. Review
  20. Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Natalia ZiętaraInstitute for Immunology, Hannover Medical School, 30625 Hannover, Germany.
Marcin Łyszkiewicz
Katrin Witzlau
Ronald Naumann
Robert Hurwitz
Jörg Langemeier
Jens Bohne
Inga Sandrock
Matthias Ballmaier
Siegfried Weiss
Immo Prinz
Andreas Krueger

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T-cell receptor (TCR) signal strength determines selection and lineage fate at the CD4(+)CD8(+) double-positive stage of intrathymic T-cell development. Members of the miR-181 family constitute the most abundantly expressed microRNA at this stage of T-cell development. Here we show that deletion of miR-181a/b-1 reduced the responsiveness of double-positive thymocytes to TCR signals and virtually abrogated early invariant natural killer T (iNKT) cell development, resulting in a dramatic reduction in iNKT cell numbers in thymus as well as in the periphery. Increased concentrations of agonist ligand rescued iNKT cell development in miR-181a/b-1(-/-) mice. Our results define a critical role of miR-181a/b-1 in early iNKT cell development and show that miR-181a/b-1 sets a TCR signaling threshold for agonist selection.

Indexed as

AnimalsCell ProliferationClonal Selection, Antigen-MediatedLigandsMiceMice, Inbred C57BLMicroRNAsNatural Killer T-CellsReceptors, Antigen, T-Cell, alpha-betaLigandsMicroRNAsmirn181 microRNA, mouseReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID23589855
PMCPMC3645533

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.